Ignite Creation Date:
2025-12-24 @ 4:55 PM
Ignite Modification Date:
2026-04-19 @ 7:37 AM
Study NCT ID:
NCT05740150
Status:
UNKNOWN
Last Update Posted:
2023-02-22
First Post:
2023-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Central Line-associated Bloodstream Infection Prevention Using TauroLock-Hep100 in Pediatric Oncology Patients.
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NL2365.041.26
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None